Medicinal cannabis APAC
APAC’s cannabis-for-medicine economy is in the second year of a permissive regulatory cycle. Atlas tracks the licensed producers, regulatory consultancies, distribution channels, and the trade shows where the deals close — anchored on Agential Cannabis (Bangkok, September 2026).
- Tracked events
- 647
- Editions this year
- 403
- Organizers
- 488
- Anchor event
- Agential CannabisSep 2026 · Bangkok, Thailand
Agential Cannabis · Bangkok, September 2026
“APAC's Premier B2B Medicinal Cannabis Business & Tech Expo.”
The B2B expo where Asian licensed producers meet international cultivation tech, where Thai regulatory pathways are explained to inbound investors, and where the pharma + agriculture + extraction-tech supply chain spends three days in one hall. Programming covers GMP-grade cultivation infrastructure, extraction equipment, lab testing, pharmaceutical formulation, and the regulatory ecosystem APAC operators have to navigate.
Events in this vertical
All 647 →Who uses medicinal-cannabis intelligence?
All solutionsFour typical jobs that pull cohort data from this vertical.
About the medicinal cannabis vertical
Global medicinal cannabis revenue crossed USD 30 billion in 2024 and is forecast to triple by 2030 (Prohibition Partners). APAC is the underserved growth pocket — North America hit saturation, Europe is fractured by national regimes, but Asian markets are entering the permissive cycle with state-level health agencies sponsoring pharmaceutical research programs.
Thailand sits at the centre: a permissive cultivation and wellness framework since 2022, GMP-certified production at scale, and a tropical climate that suits high-yield cultivation. Atlas tracks the licensed producers (cultivation, extraction, formulation), the distribution channels (clinics, dispensaries, pharma wholesalers), the regulatory consultancies guiding inbound investors, and the trade shows where the supply chain meets.
The lens is B2B medical-grade, not recreational. Where GMP licensing → pharma-grade product → clinical channel — that’s the cycle Atlas captures.
Build a year of programming around Agential Cannabis
Sponsors, exhibitors, speakers, regulators — track who’s moving in APAC cannabis B2B and where the next licensing window opens.